Key Highlights
Shares of Oscar Health fall 10.66% even after delivering record second-quarter earnings.
Total revenue jumps to $4.88 billion driven by expanded membership and higher premium rates.
Company posts $361.8 million net income compared to a $228.4 million loss in the previous year.
Full-year 2026 operating income forecast increased to up to $700 million from prior estimates.
Total membership base expands to 2.96 million as the company grows its individual insurance portfolio.
Shares of Oscar Health (OSCR) declined 10.66% to $26.90 during late-morning trading, even after the health insurer delivered robust second-quarter financial results and upgraded its full-year projections. The company reported significant revenue expansion, improved medical cost ratios, and a dramatic turnaround to profitability. Nevertheless, investors responded negatively to the announcement, sending the stock lower.
Company Delivers Record Quarterly Performance
Oscar Health reported total revenue of $4.88 billion for the second quarter, marking a substantial increase from $2.86 billion in the same period last year. The revenue surge was primarily fueled by membership expansion and premium rate increases, though risk adjustment transfers offset some of the gains. The insurer continued strengthening its position in the individual health coverage segment.
The company achieved operating income of $388.6 million, a significant reversal from the $230.5 million operating loss recorded in the prior-year quarter. Net income totaled $361.8 million, compared to a $228.4 million loss in the same quarter last year. On a per-share basis, diluted earnings came in at $1.10, versus a loss of $0.89 per share in the year-ago period.
Adjusted EBITDA surged to $415.3 million from a negative $199.4 million in the prior year. The medical loss ratio improved dramatically to 79.2% from 91.1% in the comparable quarter. Strategic pricing initiatives and $164 million in favorable reserve adjustments contributed to the enhanced profitability metrics.
Company Significantly Boosts Full-Year 2026 Projections
Oscar Health maintained its 2026 revenue guidance in the range of $18.7 billion to $19.0 billion. The company, however, substantially increased its operating income projection to between $500 million and $700 million. This represents a significant upgrade from the previous estimate of $250 million to $450 million.
The health insurer also improved its medical loss ratio guidance, now expecting it to fall between 81.5% and 82.5%. The prior forecast called for a range of 82.4% to 83.4% for the full year. This revision indicates enhanced underwriting discipline and more effective management of medical care expenses.
Additionally, Oscar Health lowered its anticipated SG&A expense ratio to a range of 15.6% to 16.1%. The company’s earlier guidance projected this metric between 15.8% and 16.3%. Improved operational efficiency and disciplined spending controls enabled the favorable adjustment.
Expanding Member Base Reinforces Competitive Standing
Oscar Health reported 2.96 million total members across its individual and related insurance products at the end of June. This represents substantial growth from 2.03 million members in the comparable period of 2025. The increase reflects sustained market demand for individual health insurance coverage.
The insurer has discontinued its small group product lines and ended its previous partnership with Cigna. Oscar Health now concentrates primarily on individual coverage products, including employer-funded individual coverage health reimbursement arrangements. This strategic focus positions the company to capitalize on shifting employment patterns and workforce mobility.
Oscar Health has leveraged pricing discipline and technology-driven solutions to drive both growth and profitability. The quarterly performance demonstrated improved underwriting results, controlled expenses, and expanded market reach. Despite these positive developments, Oscar Health stock experienced a sharp decline as investors reacted unfavorably to the earnings release.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
